Alimentary Pharmacology & Therapeutics

Review article: bowel preparation for colonoscopy - the importance of adequate hydration
pp. 633-641(9)
Authors: LICHTENSTEIN, G. R.; COHEN, L. B.; URIBARRI, J.

Meta-analysis: inosine triphosphate pyrophosphatase polymorphisms and thiopurine toxicity in the treatment of inflammatory bowel disease
pp. 643-652(10)
Authors: VAN DIEREN, J. M.; HANSEN, B. E.; KUIPERS, E. J.; NIEUWENHUIS, E. E. S.; VAN DER WOUDE, C. J.

Meta-analysis: the utility and safety of heparin in the treatment of active ulcerative colitis
pp. 653-663(11)
Authors: SHEN, J.; RAN, Z. H.; TONG, J. L.; XIAO, S. D.

One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study
pp. 665-672(8)
Authors: VAN ZANTEN, S. V.; FLOOK, N.; TALLEY, N. J.; VAKIL, N.; LAURITSEN, K.; BOLLING-STERNEVALD, E.; PERSSON, T.; BJÖRCK, E.; SVEDBERG, L.-E.

Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?
pp. 673-682(10)
Authors: TALLEY, N. J; VAKIL, N.; LAURITSEN, K.; VAN ZANTEN, S. V.; FLOOK, N.; BOLLING-STERNEVALD, E.; PERSSON, T.; BJÖRCK, E.; LIND, T.

Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study
pp. 683-691(9)
Authors: JANSSON, C.; NORDENSTEDT, H.; WALLANDER, M.-A.; JOHANSSON, S.; JOHNSEN, R.; HVEEM, K.; LAGERGREN, J.

Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori
pp. 693-703(11)
Authors: FURUTA, T.; SUGIMOTO, M.; SHIRAI, N.; MATSUSHITA, F.; NAKAJIMA, H.; KUMAGAI, J.; SENOO, K.; KODAIRA, C.; NISHINO, M.; YAMADE, M.; IKUMA, M.; WATANABE, H.; UMEMURA, K.; ISHIZAKI, T.; HISHIDA, A.

Evaluating the cost of sustained virologic response in naïve chronic hepatitis C patients treated à la carte
pp. 705-716(12)
Authors: BUTI, M.; CASADO, M. A.; ESTEBAN, R.

Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end-stage cirrhosis
pp. 717-726(10)
Authors: DONATI, G.; PISCAGLIA, F.; COLÌ, L.; SILVAGNI, E.; RIGHINI, R.; PINI, P.; STEFONI, S.; BOLONDI, L.

Virtual vs. optical colonoscopy in symptomatic gastroenterology out-patients: the case for virtual imaging followed by targeted diagnostic or therapeutic colonoscopy
pp. 727-736(10)
Authors: BOSE, M.; BELL, J.; JACKSON, L.; CASEY, P.; SAUNDERS, J.; EPSTEIN, O.

Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy
pp. 737-745(9)
Authors: PALMIERI, O.; LATIANO, A.; BOSSA, F.; VECCHI, M.; D'INCÀ, R.; GUAGNOZZI, D.; TONELLI, F.; CUCCHIARA, S.; VALVANO, M. R.; LATIANO, T.; ANDRIULLI, A.; ANNESE, V.

Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up
pp. 747-756(10)
Authors: KOHN, A.; DAPERNO, M.; ARMUZZI, A.; CAPPELLO, M.; BIANCONE, L.; ORLANDO, A.; VISCIDO, A.; ANNESE, V.; RIEGLER, G.; MEUCCI, G.; MARROLLO, M.; SOSTEGNI, R.; GASBARRINI, A.; PERALTA, S.; PRANTERA, C.

The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study
pp. 757-766(10)
Authors: PATERSON, B. M.; LAMMERS, K. M.; ARRIETA, M. C.; FASANO, A.; MEDDINGS, J. B.